PFIZER INC — Director's Dealing 2022

Mar 1, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2022-02-26

Reporting Person: DAMICO JENNIFER B. (SVP & Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-26	Common Stock	M	9713.0000	$25.6000	Acquired	26120.0000	Direct
2022-02-26	Common Stock	F	1867.0000	$47.7200	Disposed	24253.0000	Direct
2022-02-26	Common Stock	F	4535.0000	$50.6400	Disposed	19718.0000	Direct
2022-02-28	Common Stock	F	740.0000	$46.9400	Disposed	18978.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-26	Stock Appreciation Rights	$25.6000	M	9713.0000	Disposed	2022-02-26	Common Stock (9713.0000)	Direct

Footnotes

F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).

F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.

F3: Price is the closing price of Pfizer common stock on February 25, 2022.

F4: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).

F5: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

F6: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).